» Authors » Hai-Zhong Huo

Hai-Zhong Huo

Explore the profile of Hai-Zhong Huo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 53
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Cheng Y, Zhu C, Huo H
World J Clin Cases . 2022 Sep; 10(23):8336-8343. PMID: 36159541
Background: Papillary thyroid cancer (PTC) is the most common malignant tumor of the thyroid. However, the coexistence of PTC and sarcoma in one patient is rare. In this article, we...
2.
Yang J, Hua Y, Xu H, He L, Huo H, Zhu C
World J Clin Cases . 2021 Jul; 9(19):5217-5225. PMID: 34307570
Background: Leiomyomatosis peritonealis disseminata (LPD) is a rare condition characterized by multiple pelvic and abdominal nodules, which are composed of smooth-muscle cells. To date, no more than 200 cases have...
3.
Hua Y, Yang J, He L, Xu H, Huo H, Zhu C
World J Clin Cases . 2021 Jan; 9(1):252-261. PMID: 33511193
Background: Debate exists regarding the use of thermal ablation (TA) to treat papillary thyroid carcinoma (PTC). Some studies have recommended TA as a new, efficient and safe technology for PTC....
4.
Lin J, Zhang C, Zheng L, Li H, Zhu Y, Fan X, et al.
BMJ Open . 2019 Dec; 9(12):e028518. PMID: 31796472
Introduction: Portal hypertension (PH) is a severe disease with a poor outcome. Hepatic venous pressure gradient (HVPG), the current gold standard to detect PH, is available only in few hospitals...
5.
Wang L, Yan H, Cao D, Huo L, Huo H, Wang B, et al.
World J Surg Oncol . 2014 Jun; 12:133. PMID: 24885818
Background: Gastritis cystica profunda (GCP) is an uncommon disease characterized by multiple cystic gastric glands within the submucosa of the stomach. Case Description: Here, we present a case of a...
6.
Huo H, Zhou Z, Wang B, Qin J, Liu W, Gu Y
Biochem Biophys Res Commun . 2013 Dec; 443(2):406-12. PMID: 24309100
Colorectal cancer is a major contributor of cancer-related mortality. The mammalian target or rapamycin (mTOR) signaling is frequently hyper-activated in colorectal cancers, promoting cancer progression and chemo-resistance. In the current...
7.
Huo H, Wang B, Qin J, Guo S, Liu W, Gu Y
Mol Cell Biochem . 2013 Mar; 378(1-2):171-81. PMID: 23508272
Colorectal cancer is the second leading cause of cancer-related deaths. Drug resistance and/or off-target toxicity against normal cells limit the effectiveness of current chemotherapies for the treatment of colorectal cancer....